Moderna announced this Tuesday that their Covid-19 vaccine is safe and effective in adolescents. The company is basing the announcement after completing phase 2 of 3 of a trial of 3,732 children aged from 12 to 17 in the US.
Blood tests showed that the vaccine produces an immune response that was equivalent to the findings in adults.
The trial wasn’t designed to look at efficacy, but more so how safe it was for younger teens and adolescents to take it. Initial observations did show that none of the children who received the vaccine got sick with Covid-19 starting 14 days after their second dose.
“Four of the children who received the placebo tested positive for Covid-19, which is consistent with a vaccine efficacy of 100%, that figure could also change as more data is collected.”
The results also showed that the vaccine was 93% effective after one dose at preventing mild cases of Covid-19; meaning only one or two symptoms would appear in anyone who tests positive after being vaccinated.
The company said “the vaccine was generally well tolerated and no significant safety concerns were identified. Side effects included headache, fatigue, muscle pain and chills after administration of the second dose. Pain at the injection site was also sometimes observed.”
Moderna is planning on submitting the results to the US Food and Drug Administration in early June along with a request for authorization to use the vaccine in adolescents. The data will also be submitted to a peer-reviewed publication, as every other vaccine has in America.
The Moderna vaccine was already authorized in the US for individuals 18 and older, and after Moderna requests an emergency use authorization from the FDA it’s likely that it will be approved for all Americans aged 12 and up.
The FDA has already approved of the Pfizer vaccine to be given to adolescents aged between 12 and 15, previously it was only available for those 16 and older. The fact that both of these vaccines have already been used frequently in adults all across America, experts claim it makes sense that they’re both also effective in younger individuals.
According to reports from CNN, “both Pfizer and Moderna are currently testing their vaccines in younger children, ages 6 months to 11 years. Because those age groups may require varying doses, the process will likely take a little longer.”
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases recently claimed that elementary aged children likely won’t be vaccinated until the end of the year, however, he’s confident that every American, regardless of age, will be eligible by 2022.
Eric Mastrota is a Contributing Editor at The National Digest based in New York. A graduate of SUNY New Paltz, he reports on world news, culture, and lifestyle. You can reach him at email@example.com.